Healthy Skepticism Library item: 5065

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Campione JR, Sleath B, Biddle AK, Weinberger M.
The influence of physicians' guideline compliance on patients' statin adherence: a retrospective cohort study.
Am J Geriatr Pharmacother 2005 Dec; 3:(4):229-39
http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3048&uid=16503318&db=PubMed&url=http://linkinghub.elsevier.com/retrieve/pii/S1543-5946(05)00077-2

Abstract:

BACKGROUND: National cholesterol management guidelines recommend regular follow-up of patients and annual lipid evaluations to promote adherence to statin therapy. OBJECTIVE: This study examined the relationship between primary care physicians’ (PCPs’) compliance with primary care guidelines and patients’ adherence to statin therapy. METHODS: A retrospective cohort study was conducted among statin users aged > or = 50 years who had an assigned PCP at a Veterans Affairs Medical Center. The dependent variable was statin adherence by patients over 24 months. Computerized pharmacy, laboratory, and medical records were used to measure PCPs’ compliance with 4 recommendations in national cholesterol management guidelines: (1) lipid-lowering drug (LLD) initiation; (2) 8-week follow-up visit after an initial LLD prescription; (3) 6- or 12-month follow-up visit for established LLD users; and (4) annual lipid evaluation. Multilevel, multivariable regression models were used to estimate the effects of PCPs’ guideline compliance on patients’ adherence while controlling for patients’ demographic characteristics, comorbid conditions, and pharmacotherapy factors. RESULTS: The sample included 82 PCPs caring for 4707 patients. The mean statin adherence rate was 83.9%. An increase in the annual lipid evaluation rate resulted in an increase in patients’ adherence (P = 0.037). Black race and higher statin dose negatively influenced patients’ adherence (both, P < 0.001). The effects of PCPs’ compliance rates were not homogeneous across race. Specifically, the 8-week follow-up visit rate after initial LLD prescription was significantly associated with improved statin adherence among the black subpopulation only. CONCLUSIONS: Patients’ adherence to statin therapy was influenced by their PCPs’ compliance with cholesterol management guidelines. Efforts should be made to align PCPs’ practice with published guidelines for optimal statin therapy, especially for vulnerable subpopulations of patients.

Keywords:
African Continental Ancestry Group Aged Cohort Studies Ethnic Groups Female Guidelines* Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use* Male Middle Aged Patient Compliance* Patient Education Physicians, Family Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. Retrospective Studies Socioeconomic Factors Treatment Outcome